Naloxone benzylhydrazone is a μ-selective opioid antagonist without κ agonist effects in rhesus monkeys

Charles P France, J. H. Woods

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Naloxone benzoylhydrazone (NalBzoH) has been suggested to be a selective opioid agonist, exerting its effects through the κ3 subtype of opioid receptor. In the present experiments NalBzoH was studied for its discriminative stimulus, analgesic, and respiratory effects in rhesus monkeys. Up to the largest doses administered (1.0-3.2 mg/kg), NalBzoH failed to substitute for the discriminative stimulus effects of the κ agonist ethylketocyclazocine or those of the μ agonist alfentanil. However, in morphine-treated (3.2 mg/kg/day) monkeys NalBzoH substituted completely for the discriminative stimulus effects of the opioid antagonist naltrexone. NalBzoH antagonized the discriminative stimulus effects of alfentanil in morphine-treated subjects and, at larger doses, antagonized the discriminative stimulus effects of ethylketocyclazocine. NalBzoH did not produce analgesic effects and had only modest effects on respiration. However, NalBzoH antagonized the analgesic effects as well as the respiratory-depressant effects of alfentanil; at doses 10-15 times larger than those that antagonized alfentanil, NalBzoH also antagonized analgesic effects of the κ agonist U-50,488. For both μ and κ agonists, NalBzoH was slightly more potent in antagonizing discriminative stimulus effects as compared to analgesic effects. Thus, NalBzoH is a μ-selective opioid antagonist in rhesus monkeys and is equipotent to naloxone in antagonizing alfentanil. While demonstrating μ-selective antagonism, the current study fails to provide support for the proposed κ agonist actions of NalBzoH.

Original languageEnglish (US)
Pages (from-to)133-141
Number of pages9
JournalBehavioural Pharmacology
Volume3
Issue number2
StatePublished - 1992
Externally publishedYes

Fingerprint

Narcotic Antagonists
Naloxone
Macaca mulatta
Alfentanil
Analgesics
Ethylketocyclazocine
Morphine
naloxone benzoylhydrazone
Naltrexone
Opioid Receptors
Opioid Analgesics
Haplorhini
Respiration

ASJC Scopus subject areas

  • Neuroscience(all)
  • Pharmacology

Cite this

Naloxone benzylhydrazone is a μ-selective opioid antagonist without κ agonist effects in rhesus monkeys. / France, Charles P; Woods, J. H.

In: Behavioural Pharmacology, Vol. 3, No. 2, 1992, p. 133-141.

Research output: Contribution to journalArticle

@article{cbf26e06bfb847e3bb98feb45c4dd59a,
title = "Naloxone benzylhydrazone is a μ-selective opioid antagonist without κ agonist effects in rhesus monkeys",
abstract = "Naloxone benzoylhydrazone (NalBzoH) has been suggested to be a selective opioid agonist, exerting its effects through the κ3 subtype of opioid receptor. In the present experiments NalBzoH was studied for its discriminative stimulus, analgesic, and respiratory effects in rhesus monkeys. Up to the largest doses administered (1.0-3.2 mg/kg), NalBzoH failed to substitute for the discriminative stimulus effects of the κ agonist ethylketocyclazocine or those of the μ agonist alfentanil. However, in morphine-treated (3.2 mg/kg/day) monkeys NalBzoH substituted completely for the discriminative stimulus effects of the opioid antagonist naltrexone. NalBzoH antagonized the discriminative stimulus effects of alfentanil in morphine-treated subjects and, at larger doses, antagonized the discriminative stimulus effects of ethylketocyclazocine. NalBzoH did not produce analgesic effects and had only modest effects on respiration. However, NalBzoH antagonized the analgesic effects as well as the respiratory-depressant effects of alfentanil; at doses 10-15 times larger than those that antagonized alfentanil, NalBzoH also antagonized analgesic effects of the κ agonist U-50,488. For both μ and κ agonists, NalBzoH was slightly more potent in antagonizing discriminative stimulus effects as compared to analgesic effects. Thus, NalBzoH is a μ-selective opioid antagonist in rhesus monkeys and is equipotent to naloxone in antagonizing alfentanil. While demonstrating μ-selective antagonism, the current study fails to provide support for the proposed κ agonist actions of NalBzoH.",
author = "France, {Charles P} and Woods, {J. H.}",
year = "1992",
language = "English (US)",
volume = "3",
pages = "133--141",
journal = "Behavioural Pharmacology",
issn = "0955-8810",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Naloxone benzylhydrazone is a μ-selective opioid antagonist without κ agonist effects in rhesus monkeys

AU - France, Charles P

AU - Woods, J. H.

PY - 1992

Y1 - 1992

N2 - Naloxone benzoylhydrazone (NalBzoH) has been suggested to be a selective opioid agonist, exerting its effects through the κ3 subtype of opioid receptor. In the present experiments NalBzoH was studied for its discriminative stimulus, analgesic, and respiratory effects in rhesus monkeys. Up to the largest doses administered (1.0-3.2 mg/kg), NalBzoH failed to substitute for the discriminative stimulus effects of the κ agonist ethylketocyclazocine or those of the μ agonist alfentanil. However, in morphine-treated (3.2 mg/kg/day) monkeys NalBzoH substituted completely for the discriminative stimulus effects of the opioid antagonist naltrexone. NalBzoH antagonized the discriminative stimulus effects of alfentanil in morphine-treated subjects and, at larger doses, antagonized the discriminative stimulus effects of ethylketocyclazocine. NalBzoH did not produce analgesic effects and had only modest effects on respiration. However, NalBzoH antagonized the analgesic effects as well as the respiratory-depressant effects of alfentanil; at doses 10-15 times larger than those that antagonized alfentanil, NalBzoH also antagonized analgesic effects of the κ agonist U-50,488. For both μ and κ agonists, NalBzoH was slightly more potent in antagonizing discriminative stimulus effects as compared to analgesic effects. Thus, NalBzoH is a μ-selective opioid antagonist in rhesus monkeys and is equipotent to naloxone in antagonizing alfentanil. While demonstrating μ-selective antagonism, the current study fails to provide support for the proposed κ agonist actions of NalBzoH.

AB - Naloxone benzoylhydrazone (NalBzoH) has been suggested to be a selective opioid agonist, exerting its effects through the κ3 subtype of opioid receptor. In the present experiments NalBzoH was studied for its discriminative stimulus, analgesic, and respiratory effects in rhesus monkeys. Up to the largest doses administered (1.0-3.2 mg/kg), NalBzoH failed to substitute for the discriminative stimulus effects of the κ agonist ethylketocyclazocine or those of the μ agonist alfentanil. However, in morphine-treated (3.2 mg/kg/day) monkeys NalBzoH substituted completely for the discriminative stimulus effects of the opioid antagonist naltrexone. NalBzoH antagonized the discriminative stimulus effects of alfentanil in morphine-treated subjects and, at larger doses, antagonized the discriminative stimulus effects of ethylketocyclazocine. NalBzoH did not produce analgesic effects and had only modest effects on respiration. However, NalBzoH antagonized the analgesic effects as well as the respiratory-depressant effects of alfentanil; at doses 10-15 times larger than those that antagonized alfentanil, NalBzoH also antagonized analgesic effects of the κ agonist U-50,488. For both μ and κ agonists, NalBzoH was slightly more potent in antagonizing discriminative stimulus effects as compared to analgesic effects. Thus, NalBzoH is a μ-selective opioid antagonist in rhesus monkeys and is equipotent to naloxone in antagonizing alfentanil. While demonstrating μ-selective antagonism, the current study fails to provide support for the proposed κ agonist actions of NalBzoH.

UR - http://www.scopus.com/inward/record.url?scp=0026760346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026760346&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0026760346

VL - 3

SP - 133

EP - 141

JO - Behavioural Pharmacology

JF - Behavioural Pharmacology

SN - 0955-8810

IS - 2

ER -